Related Experiment Videos
Inhaled nitric oxide in cardiology practice.
C S Hayward1, R P Kelly, P S Macdonald
1Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK. c.s.hayward@ic.ac.uk
Cardiovascular Research
|February 26, 2000
Summary
Inhaled nitric oxide rapidly dilates pulmonary arteries, aiding cardiac surgery patients with pulmonary hypertension. It also helps assess vasodilator capacity and has emerging roles in platelet function and post-transplant care.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Pharmacology
Background:
- Pulmonary hypertension is a critical complication in cardiac surgery.
- Assessing pulmonary vasodilator capacity is vital for managing chronic pulmonary hypertension.
- Inhaled nitric oxide (iNO) offers targeted pulmonary vasodilation.
Purpose of the Study:
- To review the current applications of inhaled nitric oxide in cardiac medicine.
- To discuss the administration, toxicity, and clinical studies of iNO in cardiac patients.
- To explore novel uses and alternative therapies related to iNO.
Main Methods:
- Review of existing clinical studies and literature on inhaled nitric oxide.
- Analysis of iNO's role in acute and chronic pulmonary hypertension management.
- Examination of iNO's effects on platelet and leukocyte function.
Main Results:
- Inhaled nitric oxide is effective for acute post-operative pulmonary hypertension.
- iNO aids in assessing pulmonary vasodilator capacity in chronic conditions.
- Emerging roles include modifying platelet/leukocyte function and post-lung transplant care.
Conclusions:
- Inhaled nitric oxide is a valuable tool in managing pulmonary hypertension in cardiac patients.
- Further research into novel applications and alternative therapies is warranted.
- Understanding iNO's administration and toxicity is crucial for safe and effective use.